A new blood test to detect diabetic kidney disease outperforms standard of care tests

An Australian medical technology company, Proteomics International, has published a study demonstrating a new blood test significantly outperforms conventional tests in identifying the risk of diabetes-related chronic kidney disease (DKD). The blood test, called PromarkerD, has been previously validated for predicting renal decline up to four years in advance in type 2 diabetes.